The Asia Pacific ePharmacy Market would witness market growth of 17.8% CAGR during the forecast period (2021-2027).
The priorities of health systems have changed over the time since the outset of the COVID-19 pandemic. In addition, the pandemic compelled emerging nations to increase their focus on the priorities of infrastructure in non-rural centers. The pandemic emerged as a major challenge for various nations. Additionally, nations like India are focusing on taking strict actions to prevent the effects of COVID-19 and make it an opportunity to improve their healthcare infrastructure. Moreover, various government initiatives are aiming to improve and advance the healthcare system, hence, creating new growth opportunities for ePharmacy market.
The ePharmacy market in the Asia-Pacific would exhibit enormous growth in the forthcoming years. Nations like China and India are the major contributors for the ePharmacy market in the region. In addition, the Chinese government has been more involved in regulating the ePharmacy market.
Additionally, the ePharmacy market is at a developing stage in India as the number of customers is inclining towards purchasing medicines and health products through digital means. Also, ePharmacies are gradually gaining attention among customers as well as government. Moreover, around 250 ePharmacies have been set up in the nation in the past few years. Further, the demand for OTC medicines has increased in ePharmacy. Thus, these factors are anticipated to boost the growth of the regional market.
The China market dominated the Asia Pacific Over-the-Counter Products Market by Country in 2020, thereby, achieving a market value of $7,956.3 Million by 2027. The Japan market is exhibiting a CAGR of 18.3% during (2021 - 2027). Additionally, The India market is anticipated to witness a CAGR of 18.3% during (2021 - 2027).
Based on Drug Type, the market is segmented into Over-the-Counter Products and Prescription Medicines. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide ePharmacy Market is Projected to reach USD 167.6 Billion by 2027, at a CAGR of 16.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Inc., Express Scripts Holding Company (Cigna), CVS Health (CVS Pharmacy, Inc.), Optum Rx, Inc. (United Health Group), Rowlands Pharmacy (the PHOENIX group), DocMorris (Zur Rose Group AG), and Amazon Pharmacy (Amazon.com).
By Drug Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
